학술논문

Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical Outcomes
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia February 2024 24(2):122-132
Subject
Language
ISSN
2152-2650